Inventor · disambiguated record
Stephen Paul Watson
Also filed as: WATSON STEPHEN · WATSON STEPHEN P · WATSON STEPHEN PAUL
16 granted patents·9 pending applications·54 citations·filing 1992–2024
90Inventor score
Files withGLAXO GROUP LTD11NXERA PHARMA UK LTD4HEPTARES THERAPEUTICS LTD3H LUNDBECK AS2LUNDBECK & CO AS H2
Top patents by PatentIndex Score
25 records- 0176US2025136616A1Cgrp antagonist compoundsNXERA PHARMA UK LTD·Filed 2024·Application pending·0 cites
- 0272US7250439B2Matrix metalloproteinase inhibitorsGLAXO GROUP LTD·Filed 2004·Granted Jul 31, 2007·6 cites·3 claims
- 0371US9682967B2N-substituted-5-substituted phthalamic acids as sortilin inhibitorsH LUNDBECK AS·Filed 2014·Granted Jun 20, 2017·3 cites·8 claims
- 0471US7601729B2Matrix metalloproteinase inhibitorsGLAXO GROUP LTD·Filed 2004·Granted Oct 13, 2009·5 cites·15 claims
- 0570US7375248B2Inhibitors of matrix metalloproteinaseGLAXO GROUP LTD·Filed 2004·Granted May 20, 2008·4 cites·4 claims
- 0668US7476759B2Matrix metalloproteinase inhibitorsGLAXO GROUP LTD·Filed 2004·Granted Jan 13, 2009·4 cites·5 claims
- 0765US8343986B2Matrix metalloproteinase inhibitorsGLAXO GROUP LTD·Filed 2009·Granted Jan 1, 2013·0 cites·19 claims
- 0864US12227521B2CGRP antagonist compoundsNXERA PHARMA UK LTD·Filed 2020·Granted Feb 18, 2025·0 cites·31 claims
- 0964US5703240APiperidine derivativesGLAXO GROUP LTD·Filed 1994·Granted Dec 30, 1997·16 cites·20 claims
- 1061US2024376070A1Gpr52 modulator compoundsNXERA PHARMA UK LTD·Filed 2022·Application pending·0 cites
- 1156US2023348416A1Gpr52 modulator compoundsHEPTARES THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1256US2008227858A1Inhibitors of matrix metalloproteinaseGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 1355US8263602B2Matrix metalloproteinase inhibitorsGAINES SIMON·Filed 2008·Granted Sep 11, 2012·0 cites·8 claims
- 1455US2024254101A1Gpr52 modulator compoundsHEPTARES THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1554US5843966APiperidine derivativesGLAXO GROUP LTD·Filed 1997·Granted Dec 1, 1998·11 cites·21 claims
- 1653US12344621B2CGRP antagonist compoundsNXERA PHARMA UK LTD·Filed 2020·Granted Jul 1, 2025·0 cites·31 claims
- 1752US2023002374A1Gpr52 modulator compoundsHEPTARES THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1850US9321748B2Aminopyridine derived compounds as LRRK2 inhibitorsLUNDBECK & CO AS H·Filed 2013·Granted Apr 26, 2016·0 cites·19 claims
- 1949US2011065725A1Triazole amide derivatives for use in therapyGLAXO GROUP LTD·Filed 2009·Application pending·0 cites
- 2047US10195186B2N-substituted-5-substituted phthalamic acids as sortilin inhibitorsH LUNDBECK AS·Filed 2017·Granted Feb 5, 2019·0 cites·14 claims
- 2144US2019209680A1Treatment of acute liver failureUNIV BIRMINGHAM·Filed 2016·Application pending·0 cites
- 2243US5498722ABenzofuran derivativesGLAXO GROUP LTD·Filed 1994·Granted Mar 12, 1996·4 cites·16 claims
- 2342US9393248B1Aminopyridine derived compounds as LRRK2 inhibitorsLUNDBECK & CO AS H·Filed 2016·Granted Jul 19, 2016·0 cites·18 claims
- 2439US2007060596A1Heterocyclyl compoundsGIBLIN GERARD M P·Filed 2004·Application pending·0 cites
- 2532US5252593APyrazole containing benzofuran derivatives and pharmaceutical compositionsGLAXO GROUP LTD·Filed 1992·Granted Oct 12, 1993·1 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →